RUBY
Rubius Therapeutics, Inc
RUBY
RUBY
Delisted
RUBY was delisted on the 6th of March, 2023.
108 hedge funds and large institutions have $2.09B invested in Rubius Therapeutics, Inc in 2021 Q2 according to their latest regulatory filings, with 24 funds opening new positions, 44 increasing their positions, 23 reducing their positions, and 21 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
6% less capital invested
Capital invested by funds: $2.23B → $2.09B (-$139M)
20% less funds holding in top 10
Funds holding in top 10: 5 → 4 (-1)
Holders
108
Holding in Top 10
4
Calls
$12.1M
Puts
$1.02M
Top Buyers
| 1 | +$43.9M | |
| 2 | +$9.07M | |
| 3 | +$4.39M | |
| 4 |
Two Sigma Investments
New York
|
+$3.63M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$3.51M |
Top Sellers
| 1 | -$14.6M | |
| 2 | -$6.1M | |
| 3 | -$5.02M | |
| 4 |
BlackRock
New York
|
-$4.93M |
| 5 |
CLOS
Compagnie Lombard Odier SCmA
1204 Geneva,
Switzerland
|
-$4.39M |